Crispin Odey's October Gains Boost Hedge Fund Returns to 48%
(Bloomberg) -- Crispin Odey, fighting to recover from three successive years of losses in his main hedge fund, made money last month as his long-running bearish bets paid off.
The Odey European Inc. fund gained 7.2 percent in October, boosting returns for this year to 48.4 percent, according to an investor update seen by Bloomberg. It hasn't lost money in any month this year. A spokesman for London-based Odey declined to comment.
The returns contrast with widespread losses suffered by hedge funds in October as global market turmoil tripped up the $3 trillion industry, erasing most gains for the year. Funds that bet on or against equities and market trends were particularly hard-hit. Odey's fund, which had a net short equities exposure of almost 58 percent coming into the month, gained as the S&P 500 Index slumped about 7 percent in October.
Odey has long been a vocal critic of central bank policies and warned of an impending market crash, while suffering by betting on it. Odey European Inc. lost about 65 percent in three years through 2017.
This year, some of his top short bets such as Lancashire Holdings Ltd and Metro Bank Plc paid off as their shares fell. A number of Odey's long wagers such as Sky Plc were also profitable.
To contact the reporter on this story: Nishant Kumar in London at nkumar173@bloomberg.net
To contact the editors responsible for this story: Sree Vidya Bhaktavatsalam at sbhaktavatsa@bloomberg.net, Keith Campbell
©2018 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.